Donna Romero
About Donna Romero
Donna Romero serves as the Executive Vice President of Drug Discovery at ROME Therapeutics, a position she has held since 2022. With extensive experience in drug discovery and a strong academic background in chemistry, she has held various leadership roles in the pharmaceutical industry.
Current Role at ROME Therapeutics
Donna Romero serves as the Executive Vice President of Drug Discovery at ROME Therapeutics, a position she has held since 2022. In this role, she is responsible for overseeing drug discovery initiatives and leading strategic efforts in the development of new therapeutics. Her leadership in this area is pivotal to the company's mission and objectives.
Previous Experience in Drug Discovery
Prior to her current role, Donna Romero held various positions in the pharmaceutical industry. She worked at Nimbus Therapeutics as Director from 2010 to 2020, where she contributed to drug discovery projects. Before that, she served as Senior Director at Pfizer Inc from 2003 to 2007 and as Director at Pharmacia from 1998 to 2003. Her extensive experience spans over two decades in drug discovery leadership.
Educational Background
Donna Romero earned her Ph.D. in Organic Chemistry from the University of Wisconsin-Madison, where she studied from 1983 to 1987. Earlier, she obtained a B.S. in Chemistry and Computer Science/Math from Emory University, completing her studies there from 1979 to 1983. This educational foundation has equipped her with a strong background in chemistry and scientific research.
Career at Pharmacia
Donna Romero began her career at Pharmacia, where she worked as a Scientist from 1988 to 1998 for ten years. She later returned to Pharmacia as Director from 1998 to 2003. Her tenure at Pharmacia provided her with significant experience in drug discovery and development processes.
Expertise in Chemistry and Drug Hunting
Donna Romero possesses expertise in chemistry strategy and drug hunting. Her knowledge in these areas has been instrumental in her leadership roles, particularly in guiding drug discovery efforts at ROME Therapeutics and her previous positions in the pharmaceutical industry.